---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-014637"
form_type: "8-K"
ticker: "INTI"
cik: "0001042418"
company_name: "Inhibitor Therapeutics, Inc."
filed_at: "2026-04-01T23:59:59+00:00"
generated_at: "2026-05-15T07:55:40.204748+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Inhibitor Therapeutics sues investor for failing to close $3M financing

## Summary
- Filed suit March 30, 2026 against an institutional investor for breach of the Securities Purchase Agreement.
- Investor failed to fund $3,000,000 investment for 12,000,000 shares and 7,000,000 warrants at $0.25 per share.
- Company attempted to secure funds without litigation before initiating the suit.
- Additional details on the litigation to be provided in a subsequent Form 8-K.

## SEC filing metadata
- accession: 0001493152-26-014637
- form_type: 8-K
- ticker: INTI
- cik: 0001042418
- company_name: Inhibitor Therapeutics, Inc.
- filed_at: 2026-04-01T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1042418/000149315226014637/0001493152-26-014637-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1042418/000149315226014637/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-014637
- JSON: https://secwatch.observer/filing/0001493152-26-014637.json
- Plain text: https://secwatch.observer/filing/0001493152-26-014637.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.